![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Lung Cancer |
Free Subscription
1 AJR Am J Roentgenol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Lung Cancer is free of charge.
U.S. Newspaper Coverage of Lung Cancer Screening from 2010 to 2022.
AJR Am J Roentgenol. 2023 Mar 15. doi: 10.2214/AJR.23.29066.
PubMed
Abstract available
Stereotactic Body Radiation Therapy for Sarcoma Pulmonary Metastases.
Am J Clin Oncol. 2023 Mar 14. doi: 10.1097/COC.0000000000001000.
PubMed
Abstract available
Trends in location of death for individuals with metastatic lung cancer in the
United States.
Am J Surg. 2023 Feb 24:S0002-9610(23)00085-5. doi: 10.1016/j.amjsurg.2023.
PubMed
A text-mining approach to study the real-world effectiveness and potentially
fatal immune-related adverse events of PD-1 and PD-L1 inhibitors in older
patients with stage III/IV non-small cell lung cancer.
BMC Cancer. 2023;23:247.
PubMed
Abstract available
Integrated analyzes identify CCT3 as a modulator to shape immunosuppressive tumor
microenvironment in lung adenocarcinoma.
BMC Cancer. 2023;23:241.
PubMed
Abstract available
Distribution and prognostic impact of EGFR and KRAS mutations according to
histological subtype and tumor invasion status in pTis-3N0M0 lung adenocarcinoma.
BMC Cancer. 2023;23:248.
PubMed
Abstract available
Monitoring of T790M in plasma ctDNA of advanced EGFR-mutant NSCLC patients on
first- or second-generation tyrosine kinase inhibitors.
BMC Cancer. 2023;23:234.
PubMed
Abstract available
Controlling Nutritional Status (CONUT) score is a prognostic marker in III-IV
NSCLC patients receiving first-line chemotherapy.
BMC Cancer. 2023;23:225.
PubMed
Abstract available
Spatial characterization and quantification of CD40 expression across cancer
types.
BMC Cancer. 2023;23:220.
PubMed
Abstract available
3D collagen migration patterns reveal a SMAD3-dependent and TGF-beta1-independent
mechanism of recruitment for tumour-associated fibroblasts in lung
adenocarcinoma.
Br J Cancer. 2023;128:967-981.
PubMed
Abstract available
Predicting response to immune checkpoint blockade in NSCLC with tumour-only
RNA-seq.
Br J Cancer. 2023;128:1148-1154.
PubMed
Abstract available
Dual targeting of BCL-2 and MCL-1 in the presence of BAX breaks venetoclax
resistance in human small cell lung cancer.
Br J Cancer. 2023 Mar 14. doi: 10.1038/s41416-023-02219.
PubMed
Abstract available
Real-world retrospective study of KRAS mutations in advanced nonsmall cell lung
cancer in the era of immunotherapy.
Cancer. 2023 Mar 11. doi: 10.1002/cncr.34731.
PubMed
Abstract available
Tumor PD-L1 engages myeloid PD-1 to suppress type I interferon to impair
cytotoxic T lymphocyte recruitment.
Cancer Cell. 2023;41:620-636.
PubMed
Abstract available
TIP60 is required for tumorigenesis in non-small cell lung cancer.
Cancer Sci. 2023 Mar 14. doi: 10.1111/cas.15785.
PubMed
Abstract available
Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A
Retrospective Assessment Based on Resampling of the Phase III Study IMpower150.
Clin Cancer Res. 2023;29:1047-1055.
PubMed
Abstract available
Efficacy of osimertinib in patients with lung cancer positive for uncommon EGFR
exon 19 deletion mutations.
Clin Cancer Res. 2023 Mar 13:CCR-22-3497. doi: 10.1158/1078-0432.CCR-22-3497.
PubMed
Abstract available
Perioperative ctDNA-Based MRD Detection in NSCLC-Letter.
Clin Cancer Res. 2023;29:1155.
PubMed
Perioperative ctDNA-Based MRD Detection in NSCLC-Response.
Clin Cancer Res. 2023;29:1156.
PubMed
Current and Emerging Treatment Options for Patients With Relapsed Small-cell Lung
Carcinoma: A Systematic Literature Review.
Clin Lung Cancer. 2023 Feb 8:S1525-7304(23)00017.
PubMed
Abstract available
Multicentre real-world data of ramucirumab plus docetaxel after combined
platinum-based chemotherapy with programmed death-1 blockade in advanced
non-small cell lung cancer: NEJ051 (REACTIVE study).
Eur J Cancer. 2023;184:62-72.
PubMed
Abstract available
Metachronous ipsilateral lung cancer: reoperate if you can!
Eur J Cardiothorac Surg. 2023;63:ezad093.
PubMed
Clear cell mesotheliomas with inactivating VHL mutations and near-haploid genomic
features.
Genes Chromosomes Cancer. 2023;62:267-274.
PubMed
Abstract available
Cancer survival in the Faroe Islands over the last 50 years compared to the other
Nordic countries.
Int J Cancer. 2023;152:2090-2098.
PubMed
Abstract available
Female reproductive and hormonal factors and lung cancer mortality among
never-smokers: a prospective cohort study of 287 408 Chinese women.
Int J Cancer. 2023 Mar 14. doi: 10.1002/ijc.34508.
PubMed
Abstract available
A rare FGF5 candidate variant (rs112475347) for predisposition to non-squamous,
non-small-cell lung cancer.
Int J Cancer. 2023 Mar 14. doi: 10.1002/ijc.34510.
PubMed
Abstract available
Cyclovirobuxine D inhibits growth and progression of non‑small cell lung cancer
cells by suppressing the KIF11‑CDC25C‑CDK1‑CyclinB1 G(2)/M phase transition
regulatory network and the NFkappaB/JNK signaling pathway.
Int J Oncol. 2023;62:57.
PubMed
Abstract available
Repurposing of triamterene as a histone deacetylase inhibitor to overcome
cisplatin resistance in lung cancer treatment.
J Cancer Res Clin Oncol. 2023 Mar 11. doi: 10.1007/s00432-023-04641.
PubMed
Abstract available
Low diffusion capacity predicts poor prognosis in extensive stage small cell lung
cancer: a single-center analysis of 10 years.
J Cancer Res Clin Oncol. 2023 Mar 13. doi: 10.1007/s00432-023-04686.
PubMed
Abstract available
Treatment and survival of patients with metachronous colorectal lung metastases.
J Surg Oncol. 2023;127:806-814.
PubMed
Abstract available
Joint 2022 European Society of Thoracic Surgeons and The American Association for
Thoracic Surgery guidelines for the prevention of cancer-associated venous
thromboembolism in thoracic surgery.
J Thorac Cardiovasc Surg. 2023;165:794-824.
PubMed
Abstract available
Driver mutation characteristics of phosphatidylinositol-4,5-bisphosphate 3-kinase
catalytic subunit alpha (PIK3CA) in advanced non-small cell lung cancer.
Lung Cancer. 2023;178:229-236.
PubMed
Abstract available
Impact of ramucirumab pharmacokinetics in combination with docetaxel on the
efficacy and survival in patients with advanced non-small cell lung cancer.
Lung Cancer. 2023;178:247-253.
PubMed
Abstract available
MET alterations in advanced non-small cell lung cancer.
Lung Cancer. 2023;178:254-268.
PubMed
Abstract available
Age-period-cohort effect on lung cancer mortality in Spain, 1982-2021.
Lung Cancer. 2023;178:269-276.
PubMed
Abstract available
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable
non-small cell lung cancer: the phase 2 platform NEOSTAR trial.
Nat Med. 2023 Mar 16. doi: 10.1038/s41591-022-02189.
PubMed
Abstract available
Advancing neoadjuvant immunotherapy for lung cancer.
Nat Med. 2023 Mar 16. doi: 10.1038/s41591-023-02246.
PubMed
A longitudinal circulating tumor DNA-based model associated with survival in
metastatic non-small-cell lung cancer.
Nat Med. 2023 Mar 16. doi: 10.1038/s41591-023-02226.
PubMed
Abstract available
Effect of shRNA‑mediated knockdown EBF1 gene expression on the proliferation of
lung cancer cell line A549 in vitro and in vivo.
Oncol Rep. 2023;49:90.
PubMed
Abstract available
Low Risk of Hyperprogression with First-Line Chemoimmunotherapy for Advanced
Non-Small Cell Lung Cancer: Pooled Analysis of 7 Clinical Trials.
Oncologist. 2023 Mar 11:oyad043. doi: 10.1093.
PubMed
Abstract available
Non-pharmacological interventions on anxiety and depression in lung cancer
patients' informal caregivers: A systematic review and meta-analysis.
PLoS One. 2023;18:e0282887.
PubMed
Abstract available
Prevalence of lung cancer in Colombia and a new diagnostic algorithm using health
administrative databases: A real-world evidence study.
PLoS One. 2023;18:e0269079.
PubMed
Abstract available
Incidentally found resectable lung cancer with the usage of artificial
intelligence on chest radiographs.
PLoS One. 2023;18:e0281690.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by